neurodegenerative disease Archives - The Hippocratic Post

Successful patient inclusion of Phase II clinical trial for Traumatic Spinal Cord Injury

Posted on September 14, 2023 by Hippocratic Post

Neuroplast, a Dutch clinical-stage biotech, focusing on cell-based treatments for neurodegenerative diseases, has Injury (TSCI). Preliminary data indicate an excellent safety profile due to the complete absence of product related adverse events. Furthermore, patient feedback confirms excellent tolerability. The trial is conducted in collaboration with Hospital Nacional de Parapléjicos in Toledo, Spain, and Rigshospitalet in […]

High neuro degenerative risk among former international rugby players

Posted on October 17, 2022 by Hippocratic Post

A study led by the University of Glasgow has revealed the first major insights into lifelong health outcomes in former international rugby union players. In findings published in the Journal of Neurology, Neurosurgery and Psychiatry, the researchers found that former international rugby players had an approximately two and a half times higher risk of neurodegenerative […]

New tool could help Alzheimer’s Disease diagnosis

Posted on October 2, 2022 by Hippocratic Post

Coventry University researchers have developed a new tool which could help diagnose Alzheimer’s Disease. Alzheimer’s Disease (AD) is one of the most common neurodegenerative diseases, affecting 50 million patients worldwide and that figure is expected to increase by 50% by 2050. Current AD diagnosis methods like cognitive, physical and radiological assessments can be often subjective, time-consuming […]

Eye scanner targets neurodegenerative diseases

Posted on March 31, 2022 by Hippocratic Post

A multimodal eye scanner was developed as part of the MOON project. This scanner not only provides a high-resolution image of the structure using OCT but also sensitive molecular characterization of the tissue. To achieve this, the capabilities of OCT have been combined with those of Raman spectroscopy. The latter technology uses light to detect […]

Brain astrocytes show metabolic alterations in Parkinson’s disease

Posted on September 8, 2020 by Hippocratic Post

Brain astrocytes show metabolic alterations in Parkinson’s disease: A new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson’s disease (PD) pathology. The study carried out at the University of Eastern Finland and published in Scientific Reports highlights the role of brain astrocyte cells in PD pathology and the potential of iPSC-derived cells […]